Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q21098923> ?p ?o }
Showing triples 1 to 66 of
66
with 100 triples per page.
- Q21098923 subject Q7215860.
- Q21098923 subject Q8661590.
- Q21098923 subject Q8790228.
- Q21098923 subject Q8919936.
- Q21098923 subject Q9546190.
- Q21098923 abstract "L-4-Chlorokynurenine (4-Cl-KYN, developmental code name AV-101) is an orally active small molecule prodrug candidate that in vivo produces a glycine binding site NMDA receptor antagonist. AV-101 is in clinical development by VistaGen Therapeutics. Inc. as a potential new generation, fast-acting antidepressant, and for other central nervous system (CNS) indications. The initial Phase 2 clinical study of AV-101 is expected to begin in 2015 and will be focused on treatment-resistant depression (TRD) and major depressive disorder (MDD).".
- Q21098923 atcPrefix "None".
- Q21098923 bioavailability "39.0".
- Q21098923 casNumber "75802-84-5".
- Q21098923 iupacName "(2S)-2-Amino-4-(2-amino-4-chlorophenyl)-4-oxobutanoic acid".
- Q21098923 pubchem "9859632".
- Q21098923 thumbnail 4-Chlorokynurenine.svg?width=300.
- Q21098923 wikiPageExternalLink ?page_id=11.
- Q21098923 wikiPageExternalLink ?page_id=198.
- Q21098923 wikiPageWikiLink Q141124.
- Q21098923 wikiPageWikiLink Q15409412.
- Q21098923 wikiPageWikiLink Q15634175.
- Q21098923 wikiPageWikiLink Q181003.
- Q21098923 wikiPageWikiLink Q18204530.
- Q21098923 wikiPageWikiLink Q18205913.
- Q21098923 wikiPageWikiLink Q18344482.
- Q21098923 wikiPageWikiLink Q18378831.
- Q21098923 wikiPageWikiLink Q187181.
- Q21098923 wikiPageWikiLink Q1967405.
- Q21098923 wikiPageWikiLink Q221694.
- Q21098923 wikiPageWikiLink Q2273909.
- Q21098923 wikiPageWikiLink Q243547.
- Q21098923 wikiPageWikiLink Q245204.
- Q21098923 wikiPageWikiLink Q30612.
- Q21098923 wikiPageWikiLink Q334477.
- Q21098923 wikiPageWikiLink Q389934.
- Q21098923 wikiPageWikiLink Q390551.
- Q21098923 wikiPageWikiLink Q4044974.
- Q21098923 wikiPageWikiLink Q407324.
- Q21098923 wikiPageWikiLink Q411945.
- Q21098923 wikiPageWikiLink Q414896.
- Q21098923 wikiPageWikiLink Q42844.
- Q21098923 wikiPageWikiLink Q4386371.
- Q21098923 wikiPageWikiLink Q461076.
- Q21098923 wikiPageWikiLink Q47273.
- Q21098923 wikiPageWikiLink Q502961.
- Q21098923 wikiPageWikiLink Q5167908.
- Q21098923 wikiPageWikiLink Q5513673.
- Q21098923 wikiPageWikiLink Q6060674.
- Q21098923 wikiPageWikiLink Q642217.
- Q21098923 wikiPageWikiLink Q7215860.
- Q21098923 wikiPageWikiLink Q7836891.
- Q21098923 wikiPageWikiLink Q80417.
- Q21098923 wikiPageWikiLink Q8661590.
- Q21098923 wikiPageWikiLink Q8790228.
- Q21098923 wikiPageWikiLink Q8919936.
- Q21098923 wikiPageWikiLink Q9546190.
- Q21098923 wikiPageWikiLink Q9635.
- Q21098923 atcPrefix "None".
- Q21098923 bioavailability "39".
- Q21098923 casNumber "75802".
- Q21098923 iupacName "-2".
- Q21098923 pubchem "9859632".
- Q21098923 type ChemicalSubstance.
- Q21098923 type Drug.
- Q21098923 type ChemicalObject.
- Q21098923 type Thing.
- Q21098923 type Q8386.
- Q21098923 comment "L-4-Chlorokynurenine (4-Cl-KYN, developmental code name AV-101) is an orally active small molecule prodrug candidate that in vivo produces a glycine binding site NMDA receptor antagonist. AV-101 is in clinical development by VistaGen Therapeutics. Inc. as a potential new generation, fast-acting antidepressant, and for other central nervous system (CNS) indications.".
- Q21098923 label "4-Chlorokynurenine".
- Q21098923 depiction 4-Chlorokynurenine.svg.